Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L01AA01	ENDOXAN	B	Cyclophosphamide (monohydrate) - 500mg	500mg	Injectable powder for solution	764,646 L.L
L01AA01	ENDOXAN	B	Cyclophosphamide (monohydrate) - 500mg	500mg	Injectable powder for solution	L.L
B02BD02	ESPEROCT	BioTech	Turoctocog Alfa pegol (recombinant coagulation factor VIII) - 500IU/Vial	500IU/Vial	Injectable powder for solution+diluent	38,126,657 L.L
A11CC05	EURO D HP 50.000 IU	G	Vitamin D3 - 50,000IU	50,000IU	Capsule	1,432,536 L.L
N01BB54	EMLA	B	Prilocaine - 25mg/g, Lidocaine - 25mg/g	5%	Cream	1,763,121 L.L
L01BC02	EFUDIX	B	Fluorouracil - 5%	5%	Cream	671,921 L.L
S01LA05	EYLEA	BioTech	Aflibercept - 40mg/ml	40mg/ml	Injectable solution	L.L
S01LA05	EYLEA	BioTech	Aflibercept - 40mg/ml	40mg/ml	Injectable solution	65,161,855 L.L
L02BB04	ENZASTIK 40	G	Enzalutamide - 40mg	40mg	Capsule	82,838,963 L.L
A02BC01	ESELAN	G	Omeprazole (sodium) - 40mg	40mg	Injectable lyophilised powder for solution	2,073,549 L.L
C10AA05	EMITOR	G	Atorvastatin - 40mg	40mg	Tablet, film coated	1,060,292 L.L
A02BC05	ESO TAD	G	Esomeprazole - 40mg	40mg	Capsule, hard, gastro-resistant	389,714 L.L
A02BC05	ESOCAP-UBSA	G	Esomeprazole - 40mg	40mg	Capsule	646,324 L.L
A02BC05	ESOFLUX	G	Esomeprazole - 40mg	40mg	Capsule	646,324 L.L
A02BC05	ESOMEP	G	Esomeprazole - 40mg	40mg	Tablet, gastroresistant	493,392 L.L
A02BC05	ESOMEPRAZOLE ARROW LAB	G	Esomeprazole - 40mg	40mg	Capsule, gastro-resistant	454,219 L.L
C09CA09	EDARBI	B	Azilsartan medoxomil - 40mg	40mg	Tablet	1,846,440 L.L
A02BC05	ESOMEPRAZOLE BIOGARAN	G	Esomeprazole (magnesium dihydrate) - 40mg	40mg	Capsule, gastro-resistant	513,348 L.L
A02BC05	EXONAR	G	Esomeprazole (magnesium trihydrate) - 40mg	40mg	Capsule, delayed release	639,925 L.L
A02BC05	ESAC	G	Esomeprazole sodium - 40mg	40mg	Injectable powder for solution	430,030 L.L
A02BC05	ESOMEPRAZOLE NORMON	G	Esomeprazole - 40mg	40mg	Injectable powder for solution	430,030 L.L
A02BC05	ESSIUM	G	Esomeprazole - 40mg	40mg	Injectable powder for solution	314,459 L.L
L02BB04	ENZASTIK 40	G	Enzalutamide - 40mg	40mg	Capsule	L.L
A06AD04	EPSOM SALT	G	Magnesium sulfate - 40g	40g	Granules	89,590 L.L
J01MA14	EVAFLOX	G	Moxifloxacin (HCl) - 400mg	400mg	Tablet, film coated	669,234 L.L
B03XA01	EPOMAX	BioTech	Erythropoietin recombinant human (Epoetin alfa) - 4000UI/ml	4000UI/ml	Injectable solution	1,243,054 L.L
B03XA01	EPOMAX	BioTech	Erythropoietin recombinant human (Epoetin alfa) - 4000UI/ml	4000UI/ml	Injectable solution	L.L
B01AB05	ENOXAPARIN LEDRAXEN	BioTech	Enoxaparin sodium - 4000UI (40mg)/0.4ml	4000UI (40mg)/0.4ml	Injectable solution	841,245 L.L
B01AB05	ENOMEX	BioTech	Enoxaparin sodium - 4000U Anti-Xa/0.4ml	4000U Anti-Xa/0.4ml	Injectable solution	753,832 L.L
B01AB05	ENOXAMED	BioTech	Enoxaparin sodium - 4000IU Anti-XA/0.4ml	4000IU Anti-XA/0.4ml	Injectable solution	755,239 L.L

...